Source: Sanofi (EURONEXT: SAN) (NASDAQ:
SNY)
- First global biopharmaceutical company with a presence in
Canada to be certified by Women in
Governance
LAVAL, QC, Sept. 26, 2019
/CNW Telbec/ - Sanofi Canada is pleased to announce that the
company has reached a great milestone: our first Parity
Certification from the Women in Governance organization. This
certification means that Sanofi Canada has taken its place among
notable Canadian companies that strive towards gender parity.
"Being the first global biopharmaceutical company with a
presence in Canada to achieve this
certification is very meaningful to our entire team, and we are
proud to add it to our list of accomplishments in this country,"
says Michael Mullette, President and
CEO of Sanofi Canada. "Gender parity is a key part of Sanofi's core
values, and our ongoing commitment to inclusion and diversity in
the workplace."
Inclusion and diversity are foundational to how Sanofi operates.
We recognize the benefits in the workplace, and strive to foster an
environment where differences can thrive and be leveraged to
empower the lives of patients.
"This certification is a recognition of our hard work and
determination towards gender parity and will continue to be a
source of motivation for the Sanofi team," says Marie-Pierre Lalande, Head of Sanofi Canada
Human Resources. "We will continue to support and empower every
member of our organization to embrace an inclusive culture across
the country."
Women in Governance is a not-for-profit organization founded to
empower women in their roles as employees and leaders in their
quest towards excellence. Their objective is to close the gender
gap in the workplace and achieve parity at every level and
department of an organization. More information is available at
www.womeningovernance.org.
About Sanofi – www.sanofi.ca
Sanofi is dedicated to supporting people through their health
challenges. We are a global biopharmaceutical company focused on
human health. We prevent illness with vaccines, provide innovative
treatments to fight pain and ease suffering. We stand by the few
who suffer from rare diseases and the millions with long-term
chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is
transforming scientific innovation into healthcare solutions around
the globe. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi entities in Canada
include the Diabetes and Cardiovascular Care Business Unit, the
General Medicines and Established Products Business Unit, Sanofi
Pasteur (vaccines), Sanofi Genzyme (specialty care) and Sanofi
Consumer Health. Together, we employ close to 1,900 people in
Canada. In 2016, Sanofi companies
invested $130 million in research and
development in Canada, creating
jobs, economic activity and opportunity throughout the country.
Follow us on Twitter @SanofiCanada and on YouTube.
SOURCE Sanofi-Aventis Canada Inc.